(c) 2024 PillSync.com

sildenafil citrate 50 mg

1 INDICATIONS AND USAGE Sildenafil tablets are indicated for the treatment of erectile dysfunction. Sildenafil is a phosphodiesterase-5 (PDE5) inhibitor indicated for the treatment of erectile dysfunction (ED)

nivagen pharmaceuticals, inc.


2 years ago OVAL BLUE 1A2 sildenafil citrate 50 mg

OVAL BLUE 1A2

2 years ago OVAL BLUE 1A2 sildenafil citrate 50 mg

1A2 OVAL BLUE

16 HOW SUPPLIED/STORAGE AND HANDLING Sildenafil tablets USP are supplied as pale blue to blue, caplet shaped film-coated tablets containing

SILDENAFIL CITRATE equivalent to the nominally indicated amount of sildenafil as follows: For 100 mg - Pale blue to blue, caplet shaped film-coated tablets, debossed with ‘1A1’ on one side and plain on other side. For 50 mg - Pale blue to blue, caplet shaped film-coated tablets, debossed with ‘1A2’ on one side and plain on other side. For 25 mg - Pale blue to blue, round film-coated tablets, debossed with “25” on one side and “SL” on other side. 25 mg 50 mg 100 mg Bottle of 30 tablets 75834-272-30 NDC 75834-240-30 NDC 75834-241-30 Bottle of 90 tablets 75834-272-90 - - Bottle of 100 tablets - NDC 75834-240-01 NDC 75834-241-01 Bottle of 500 tablets - NDC 75834-240-05 NDC 75834-241-05 Bottle of 1000 tablets 75834-272-00 NDC 75834-240-00 NDC 75834-241-00 Recommended Storage: Store at 25°C (77°F); excursions permitted within 15-30°C (59-86°F) [see USP Controlled Room Temperature].


More pills like OVAL 1A2

Related Pills

sildenafil citrate 100 mg

NIVAGEN PHARMACEUTICALS, INC.

sildenafil citrate 100 mg

NIVAGEN PHARMACEUTICALS, INC.

sildenafil citrate 100 mg

NIVAGEN PHARMACEUTICALS, INC.

sildenafil citrate 50 mg

nivagen pharmaceuticals, inc.












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site